This in vitro data was further validated in primary stromal cells from APL and AML, demonstrating a significant increase in expression of LEF1 and TCF3, with a moderate increase in JAG1 & AXIN2 suggestive of variation could be individual and context-dependent (Fig. 5e). This evidence concerns the gene AXIN2 and acute myeloid leukemia.